Brevan Howard Capital Management’s Hims & Hers Health HIMS Stock Holding History

Brevan Howard Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Buy	38,148 +19,960	+110%	+$536K	0.01%	930
2026 Q1	$378K	Sell	18,188 -19,857	-52%	-$469K	﹤0.01%	1468
2025 Q4	$1.24M	Buy	38,045 +27,013	+245%	+$1.16M	0.01%	671
2025 Q3	$626K	Sell	11,032 -40,516	-79%	-$2.08M	﹤0.01%	1169
2025 Q2	$2.57M	Buy	51,548 +3,394	+7%	+$153K	0.01%	634
2025 Q1	$1.42M	Sell	48,154 -29,950	-38%	-$1.11M	0.01%	383
2024 Q4	$1.89M	Buy	78,104 +16,725	+27%	+$414K	0.01%	298
2024 Q3	$1.13M	Buy	+61,379	New	+$1.1M	0.01%	418
2024 Q1	–	Sell	-10,195	Closed	-$90.7K	–	1136
2023 Q4	$90.7K	Buy	+10,195	New	+$75.4K	﹤0.01%	968

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brevan Howard Capital Management's HIMS Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Hims & Hers Health (HIMS) stake by 110% in Q2 2026, buying an estimated $536K and bringing the position to 38,148 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #930.

Brevan Howard Capital Management first reported a position in HIMS in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.57M in Q2 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Brevan Howard Capital Management held 38,148 shares of Hims & Hers Health worth $1.32M as of Q2 2026.
Brevan Howard Capital Management bought 19,960 Hims & Hers Health shares in Q2 2026, an estimated $536K.
Hims & Hers Health made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #930 holding.
Brevan Howard Capital Management first reported a position in Hims & Hers Health in Q4 2023 and has held it in 9 quarters since.
Brevan Howard Capital Management's Hims & Hers Health position peaked at $2.57M in Q2 2025.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.